Oncolytics Biotech (TSE:ONC) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Oncolytics Biotech, a leader in immunotherapy for cancer, has announced a conference call to discuss its second quarter financial results and recent company developments. The event is scheduled for August 1, 2024, and will cover corporate updates and financial performance, highlighting the progress of their leading immunotherapeutic agent, pelareorep.
For further insights into TSE:ONC stock, check out TipRanks’ Stock Analysis page.